Get the Stockscreener App
8.24
0.72%
-0.06
After Hours:
8.16
-0.08
-0.97%
Alvotech stock is traded at $8.24, with a volume of 420.26K.
It is down -0.72% in the last 24 hours and up +2.62% over the past month.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
See More
Previous Close:
$8.30
Open:
$8.3
24h Volume:
420.26K
Relative Volume:
1.08
Market Cap:
$2.59B
Revenue:
$391.87M
Net Income/Loss:
$-441.45M
P/E Ratio:
-4.4541
EPS:
-1.85
Net Cash Flow:
$-301.21M
1W Performance:
-0.96%
1M Performance:
+2.62%
6M Performance:
+0.49%
1Y Performance:
-35.88%
1-Day Range:
$7.97
$8.30
1-Week Range:
$7.97
$8.96
52-Week Range:
$7.35
$13.70
Alvotech Stock (ALVO) Company Profile
Compare ALVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
8.24 | 2.59B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-23-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-14-25 | Initiated | UBS | Buy |
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Upgrade | Citigroup | Sell → Neutral |
| Sep-21-23 | Initiated | Barclays | Equal Weight |
| Sep-07-22 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-06-22 | Downgrade | Citigroup | Buy → Sell |
| Jul-26-22 | Initiated | Citigroup | Buy |
View All
Alvotech Stock (ALVO) Latest News
Volume spikes in Alvotech stock – what they meanWeekly Volume Report & Safe Capital Growth Trade Ideas - newser.com
Statistical indicators supporting Alvotech Equity Warrant’s strengthPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
How to read the order book for AlvotechJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
Using Ichimoku Cloud for Alvotech technicalsCPI Data & Stock Market Timing Techniques - newser.com
Analyzing Alvotech with risk reward ratio chartsJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
Will Alvotech (Z45) stock beat revenue estimatesJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Will Alvotech Equity Warrant stock benefit from green energy trendsJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
News impact scoring models applied to Alvotech Equity Warrant2025 Major Catalysts & Entry Point Confirmation Signals - newser.com
Alvotech Equity Warrant stock trend outlook and recovery path2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
Comparing Alvotech Equity Warrant in custom built stock radarsM&A Rumor & Technical Pattern Based Signals - newser.com
What does recent volatility data suggest for AlvotechJuly 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com
Alvotech's (ALVO) Sell (E+) Rating Reiterated at Weiss Ratings - MarketBeat
Here's How Alvotech is Expanding its Portfolio Beyond Immunology - MSN
Alvotech And Advanz Celebrate EU Omalizumab Filing - insights.citeline.com
My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
Alvotech’s AVT23 Biosimilar Gains EMA Acceptance - TipRanks
ALVO: EMA Begins Review of AVT23; Advanz Holds Commercial Rights - Stock Titan
Will Alvotech Equity Warrant stock recover after recent dropBuy Signal & Momentum Based Trading Ideas - newser.com
EMA accepts application for Alvotech's AVT23 - Biostock
Advanz Pharma and Alvotech Announce EMA Acceptance of Marketing Application for Biosimilar AVT23 to Xolair® - Quiver Quantitative
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency - Yahoo
Real time breakdown of Alvotech Equity Warrant stock performanceQuarterly Profit Report & Daily Profit Focused Screening - newser.com
EMA Recommendations for AVT03 and Gobivaz Could Be a Game Changer for Alvotech (ALVO) - simplywall.st
Will Alvotech benefit from macro trendsTrade Exit Report & Verified Short-Term Trading Plans - newser.com
Visual analytics tools that track Alvotech performanceJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Can Alvotech Equity Warrant recover in the next quarterPortfolio Risk Report & Reliable Entry Point Alerts - newser.com
A Fresh Look at Alvotech (NasdaqGM:ALVO) Valuation as Investors Weigh Biotech Prospects - simplywall.st
A Fresh Look at Alvotech (NasdaqGM:ALVO) Valuation After Recent Stock Uptick - Yahoo Finance
Alvotech (NasdaqGM:ALVO): Is the Market Overlooking Its True Value? - simplywall.st
Is Alvotech (Z45) stock a safe buy pre earningsEarnings Recap Report & Accurate Technical Buy Alerts - newser.com
How supply chain issues affect Alvotech Equity Warrant stockEarnings Summary Report & Expert Curated Trade Setup Alerts - newser.com
Alvotech Equity Warrant stock trendline breakdownJuly 2025 Action & Verified Entry Point Detection - newser.com
Why ETFs are accumulating Alvotech (Z45) stockQuarterly Portfolio Summary & Target Return Focused Picks - newser.com
How Alvotech Equity Warrant stock performs in high volatility markets2025 Growth vs Value & Long-Term Growth Plans - newser.com
Is Alvotech Equity Warrant stock vulnerable to regulatory risksJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - newser.com
What candlestick patterns are forming on Alvotech Equity WarrantQuarterly Market Review & Real-Time Sentiment Analysis - newser.com
Is Alvotech Equity Warrant stock supported by innovation pipelineJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Volume spikes in Alvotech Equity Warrant stock – what they meanRecession Risk & Safe Entry Point Identification - newser.com
Will Alvotech stock outperform tech sector in 2025July 2025 Earnings & Smart Investment Allocation Insights - newser.com
Alvotech Stock (ALVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):